Prader-Willi Syndrome (PWS) Therapeutics Market By Product ( Beloranib, Betahistine Hydrochloride, Diazoxide Choline CR, FE-992097, NOX-B11 ), By Application ( Clinics, Hospitals ), Industry Trends, Estimation & Forecast, 2017 - 2025

Check Today's Best Price

$3500 Buy Now
Prader-Willi Syndrome (PWS) Therapeutics Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.
  • Market Overview:

    The global Prader-Willi syndrome (PWS) therapeutics market is a nascent market with tremendous growth potential during the upcoming years. Prader-Willi syndrome is a genetic disorder caused due to the deletion of a part of father’s chromosome 15. However, PWS can also be caused due to the presence of two copies of chromosome 15 inherited by the mother only, leading to their suppression while gene formation. PWS therapeutics has wide scope in the global market, as there is no known cure available for such a complex genetic disorder. According to the International Prader-Willi Syndrome Organization, 1 in 12,000 to 15,000 people has Prader-Willi syndrome disorder. It has been recognized as a most common disorder in genetic clinics and a common genetic cause for obesity.

    The Prader-Willi syndrome (PWS) market encompasses drugs, therapies, and devices that are still in their discovery phase, clinical trial phase, and even at a safety approval phase. The Foundation for Prader-Willi Research is an active organization that has been contributing towards the development of PWS therapeutics. It has been funding research developments that are working on various approaches to cure or overcome PWS, such as genetic therapies, obesity drugs, behavior & appetite drugs, devices. However, all these developments are still in their development phases. The market players are investing heavily in their R&D activities in order to introduce effective cure for PWS and gain its FDA approval.

    The report provides detailed qualitative and quantitative analysis of the global Prader-Willi syndrome (PWS) therapeutics market. Market size and forecast in terms of value and volume has been provided for the period – (2017 – 2025), for the segments namely product, application in each of the major regions of the world.

    Prader-Willi Syndrome (PWS) Therapeutics Market Segmentation

    By Product
    • Beloranib
    • Betahistine Hydrochloride
    • Diazoxide Choline CR
    • FE-992097
    • NOX-B11
    • Others

    By Application
    • Clinic
    • Hospital
    • Others

    By Geography

    • North America
    o U.S.
    o Canada
    o Mexico

    Europe
    o U.K
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific
    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

    • South America
    o Brazil
    o Rest of South America

    • Rest of the World
    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources

    CHAPTER 2. PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET OVERVIEW
    2.1. PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET INTRODUCTION
    2.2. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
    2.2.1. Global Prader-Willi Syndrome (PWS) Therapeutics Production (VOLUME) and Growth Rate (%), (2017-2025)
    2.3. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET CAPACITY AND GROWTH RATE, 2017-2025
    2.3.1. Global Prader-Willi Syndrome (PWS) Therapeutics Capacity (VOLUME) and Growth Rate (%), (2017-2025)
    2.4. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.4.1. Global Prader-Willi Syndrome (PWS) Therapeutics Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
    2.5. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
    2.5.1. Global Prader-Willi Syndrome (PWS) Therapeutics Consumption (VOLUME) and Growth Rate (%), (2017-2025)
    2.6. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET PRICE TREND, 2017-2025
    2.6.1. Global Prader-Willi Syndrome (PWS) Therapeutics Market Price Trend and Growth Rate (%), (2017-2025)

    CHAPTER 3. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET BY PRODUCT, 2017-2025
    3.1. BETAHISTINE HYDROCHLORIDE
    3.2. BELORANIB
    3.3. DIAZOXIDE CHOLINE CR
    3.4. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET REVENUE BY PRODUCT, 2017-2025
    3.4.1. Global Prader-Willi Syndrome (PWS) Therapeutics Market Revenue (Million USD) and Share (%) By Product, 2017-2025
    3.4.2. Betahistine Hydrochloride Market Revenue and Growth Rate, 2017-2025
    3.4.3. Beloranib Market Revenue and Growth Rate, 2017-2025
    3.4.4. Diazoxide Choline CR Market Revenue and Growth Rate, 2017-2025
    3.5. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET PRODUCTION BY PRODUCT, 2017-2025
    3.5.1. Global Prader-Willi Syndrome (PWS) Therapeutics Market Production (Volume) and Share (%) By Product, 2017-2025
    3.5.2. Betahistine Hydrochloride Market Production and Growth Rate, 2017-2025
    3.5.3. Beloranib Market Production and Growth Rate, 2017-2025
    3.5.4. Diazoxide Choline CR Market Production and Growth Rate, 2017-2025

    Note: Similar information coverage has been provided for other product segment.

    CHAPTER 4. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET BY APPLICATION, 2017-2025
    4.1. HOSPITAL
    4.2. CLINIC
    4.3. OTHERS
    4.4. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET REVENUE BY APPLICATION, 2017-2025
    4.4.1. Global Prader-Willi Syndrome (PWS) Therapeutics Market Revenue (Million USD) and Share (%) By Application, 2017-2025
    4.4.2. Hospital Market Revenue and Growth Rate, 2017-2025
    4.4.3. Clinic Market Revenue and Growth Rate, 2017-2025
    4.4.4. Others Market Revenue and Growth Rate, 2017-2025
    4.5. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET CONSUMPTION BY APPLICATION, 2017-2025
    4.5.1. Global Prader-Willi Syndrome (PWS) Therapeutics Market Consumption (Volume) and share (%) By Application, 2017-2025
    4.5.2. Hospital Market Consumption and Growth Rate, 2017-2025
    4.5.3. Clinic Market Consumption and Growth Rate, 2017-2025
    4.5.4. Others Market Consumption and Growth Rate, 2017-2025

    CHAPTER 5. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET BY REGION, 2017-2025
    5.1. NORTH AMERICA
    5.1.1. U.S.
    5.1.2. Canada
    5.1.3. Mexico
    5.2. EUROPE
    5.2.1. U.K.
    5.2.2. France
    5.2.3. Germany
    5.2.4. Italy
    5.2.5. Spain
    5.2.6. Rest of Europe
    5.3. ASIA PACIFIC
    5.3.1. China
    5.3.2. Japan
    5.3.3. India
    5.3.4. Korea
    5.3.5. Rest of APAC
    5.4. SOUTH AMERICA
    5.4.1. Brazil
    5.4.2. Rest of South America
    5.5. REST OF THE WORLD
    5.5.1. Middle East
    5.5.2. Africa
    5.6. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET REVENUE BY REGION, 2017-2025
    5.6.1. Global Prader-Willi Syndrome (PWS) Therapeutics Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    5.6.2. North America Market Revenue and Growth Rate, 2017-2025
    5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
    5.6.5. South America Market Revenue and Growth Rate, 2017-2025
    5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

    CHAPTER 6. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
    6.1. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
    6.1.1. Global Prader-Willi Syndrome (PWS) Therapeutics Market Production (Volume) and Share (%) By Region, 2017-2025
    6.1.2. Global Prader-Willi Syndrome (PWS) Therapeutics Market Consumption (Volume) and Share (%) By Region, 2017-2025
    6.1.3. North America Market Production and Consumption, 2017-2025
    6.1.4. Europe Market Production and Consumption, 2017-2025
    6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
    6.1.6. South America Market Production and Consumption, 2017-2025
    6.1.7. Rest of the World Market Production and Consumption, 2017-2025

    CHAPTER 7. MARKET DETERMINANTS
    7.1. MARKET DRIVERS
    7.2. MARKET RESTRAINTS
    7.3. MARKET OPPORTUNITIES
    7.4. MARKET DETERMINANTS RADAR CHART

    CHAPTER 8. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET COMPETITION BY MANUFACTURERS
    8.1. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    8.1.1. Global Prader-Willi Syndrome (PWS) Therapeutics Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
    8.2. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
    8.2.1. Global Prader-Willi Syndrome (PWS) Therapeutics Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
    8.3. PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET COMPETITIVE SITUATION AND TRENDS
    8.3.1. Prader-Willi Syndrome (PWS) Therapeutics Market Share (%) of Top 3 Manufacturers
    8.3.2. Prader-Willi Syndrome (PWS) Therapeutics Market Share (%) of Top 5 Manufacturers

    CHAPTER 9. GLOBAL PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MANUFACTURERS ANALYSIS
    9.1. ESSENTIALIS, INC.
    9.1.1. Business Overview
    9.1.2. Company Basic Information
    9.1.3. Prader-Willi Syndrome (PWS) Therapeutics Product Details
    9.1.4. Essentialis, Inc. Prader-Willi Syndrome (PWS) Therapeutics Production, Revenue and Gross Margin
    9.2. CHONG KUN DANG PHARMACEUTICAL CORP.
    9.2.1. Business Overview
    9.2.2. Company Basic Information
    9.2.3. Prader-Willi Syndrome (PWS) Therapeutics Product Details
    9.2.4. Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome (PWS) Therapeutics Production, Revenue and Gross Margin
    9.3. FERRING INTERNATIONAL CENTER S.A.
    9.3.1. Business Overview
    9.3.2. Company Basic Information
    9.3.3. Prader-Willi Syndrome (PWS) Therapeutics Product Details
    9.3.4. Ferring International Center S.A. Prader-Willi Syndrome (PWS) Therapeutics Production, Revenue and Gross Margin 38
    9.4. P2D BIOSCIENCE
    9.4.1. Business Overview
    9.4.2. Company Basic Information
    9.4.3. Prader-Willi Syndrome (PWS) Therapeutics Product Details
    9.4.4. P2D Bioscience Prader-Willi Syndrome (PWS) Therapeutics Production, Revenue and Gross Margin
    9.5. LG LIFE SCIENCES, LTD.
    9.5.1. Business Overview
    9.5.2. Company Basic Information
    9.5.3. Prader-Willi Syndrome (PWS) Therapeutics Product Details
    9.5.4. LG Life Sciences, Ltd. Prader-Willi Syndrome (PWS) Therapeutics Production, Revenue and Gross Margin
    9.6. PFIZER INC.
    9.6.1. Business Overview
    9.6.2. Company Basic Information
    9.6.3. Prader-Willi Syndrome (PWS) Therapeutics Product Details
    9.6.4. Pfizer Inc. Prader-Willi Syndrome (PWS) Therapeutics Production, Revenue and Gross Margin
    9.7. INSYS THERAPEUTICS INC
    9.7.1. Business Overview
    9.7.2. Company Basic Information
    9.7.3. Prader-Willi Syndrome (PWS) Therapeutics Product Details
    9.7.4. Insys Therapeutics Inc Prader-Willi Syndrome (PWS) Therapeutics Production, Revenue and Gross Margin
    9.8. SANIONA AB
    9.8.1. Business Overview
    9.8.2. Company Basic Information
    9.8.3. Prader-Willi Syndrome (PWS) Therapeutics Product Details
    9.8.4. Saniona AB Prader-Willi Syndrome (PWS) Therapeutics Production, Revenue and Gross Margin
    9.9. MILLENDO THERAPEUTICS INC
    9.9.1. Business Overview
    9.9.2. Company Basic Information
    9.9.3. Prader-Willi Syndrome (PWS) Therapeutics Product Details
    9.9.4. Millendo Therapeutics Inc Prader-Willi Syndrome (PWS) Therapeutics Production, Revenue and Gross Margin
    9.10. OPTINOSE US INC
    9.10.1. Business Overview
    9.10.2. Company Basic Information
    9.10.3. Prader-Willi Syndrome (PWS) Therapeutics Product Details
    9.10.4. OptiNose US Inc Prader-Willi Syndrome (PWS) Therapeutics Production, Revenue and Gross Margin

    CHAPTER 10. PRADER-WILLI SYNDROME (PWS) THERAPEUTICS MARKET VALUE CHAIN ANALYSIS
    10.1. PRADER-WILLI SYNDROME (PWS) THERAPEUTICS INDUSTRIAL CHAIN ANALYSIS
    10.2. PRADER-WILLI SYNDROME (PWS) THERAPEUTICS KEY RAW MATERIALS ANALYSIS
    10.2.1. Key Raw Materials
    10.2.2. Price Trend of Key Raw Materials
    10.2.3. Key Suppliers of Raw Materials
    10.3. MARKETING CHANNEL
    10.3.1. Direct Marketing
    10.3.2. Indirect Marketing
    10.3.3. Distributors/Traders
    10.4. CONSUMER ANALYSIS
    10.4.1. Consumer 1
    10.4.2. Consumer 2
    10.4.3. Consumer 3
    10.4.4. Consumer 4

    keyboard_arrow_up
  • • Chong Kun Dang Pharmaceutical Corp.
    • Essentialis, Inc.
    • Ferring International Center S.A.
    • LG Life Sciences, Ltd.
    • P2D Bioscience
    • Pfizer Inc.
    • Rhythm Pharmaceuticals
    • Insys Therapeutics Inc
    • Millendo Therapeutics Inc
    • OptiNose US Inc
    • Saniona AB
    • Soleno Therapeutics Inc
    • Zafgen Inc

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Prader-Willi Syndrome (PWS) Therapeutics Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Prader-Willi Syndrome (PWS) Therapeutics Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

You may also like

CLIENTS

SHARE YOUR CART